Latin America Monoclonal Antibodies For Cancer Market Product Type (Bevacizumab, Cetumaximab, Ipilimumab, Nivolumab, Pembrolizumab, Pertuzumab, Rituximab, Trastuzumab Trastuzumab and Emtansine), Cancer Type (Breast Cancer, Colorectal Cancer, Lung Cancer, Ovarian Cancer, Blood Cancer, Melanoma, Liver Cancer and Others), Source (Humanized mAb, Human mAb and Chimeric mAb), End-User (Hospitals, Research Institutes and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: April 2025
- Report ID: 145515
- Number of Pages: 227
- Format:
-
keyboard_arrow_up
-
-
- Hoffmann-La Roche Ltd.
- Bristol-Myers Squibb Company
- Merck & Co.
- GSK plc.
- Johnson & Johnson
- Novartis AG
- AstraZeneca plc
- Eli Lilly and Company
- AbbVie Inc.
- Amgen, Inc.
Our Clients
Kickstart 2026 with Exclusive Savings
✖
Request a Sample Report
We'll get back to you as quickly as possible